Orthofix Medical Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Orthofix Medical Inc. (OFIX) reported Increase (Decrease) in Restricted Cash for Operating Activities of -$14.37 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-02-26
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-12-31 was $0.00.
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-09-30 was $0.00.
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-06-30 was $0.00.
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-03-31 was -$14.37M.
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for fiscal 2017 was -$14.37M, a 200.00% decline from fiscal 2016.
- Orthofix Medical Inc. increase (decrease) in restricted cash for operating activities for fiscal 2016 was $14.37M.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | -$14.37M 10-K · filed 2018-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $0.00 derived: sum of 2 quarters · filed 2017-10-30 | -$14.37M 10-Q · filed 2017-10-30 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$14.37M 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | -$14.37M 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | $14.37M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |